No connection

Search Results

BDX vs ZTS

BDX
Becton, Dickinson and Company
NEUTRAL
Price
$156.41
Market Cap
$56.67B
Sector
Healthcare
AI Confidence
90%
ZTS
Zoetis Inc.
BULLISH
Price
$120.82
Market Cap
$53.39B
Sector
Healthcare
AI Confidence
88%

Valuation

P/E Ratio
BDX
25.56
ZTS
20.34
Forward P/E
BDX
11.57
ZTS
19.06
P/B Ratio
BDX
1.76
ZTS
9.88
P/S Ratio
BDX
2.58
ZTS
5.68
EV/EBITDA
BDX
10.52
ZTS
14.65

Profitability

Gross Margin
BDX
46.78%
ZTS
71.74%
Operating Margin
BDX
13.35%
ZTS
39.33%
Profit Margin
BDX
8.01%
ZTS
28.21%
ROE
BDX
6.96%
ZTS
49.87%
ROA
BDX
4.08%
ZTS
15.09%

Growth

Revenue Growth
BDX
1.6%
ZTS
0.5%
Earnings Growth
BDX
28.6%
ZTS
8.5%

Financial Health

Debt/Equity
BDX
0.77
ZTS
1.35
Current Ratio
BDX
1.05
ZTS
3.64
Quick Ratio
BDX
0.37
ZTS
2.01

Dividends

Dividend Yield
BDX
2.67%
ZTS
1.66%
Payout Ratio
BDX
68.14%
ZTS
32.53%

AI Verdict

BDX NEUTRAL

BDX shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.

Strengths
Company has established market presence
Risks
Limited historical data available for full assessment
ZTS BULLISH

Zoetis Inc. (ZTS) presents a compelling investment opportunity despite near-term price underperformance, with shares down 29.9% over the past year. The company demonstrates exceptional profitability, including a 39.33% operating margin and 49.87% ROE—both materially above sector averages—while maintaining consistent earnings growth and a strong track record of beating estimates in 3 of the last 4 quarters. Valuation remains attractive relative to peers, trading at a forward P/E of 19.06 versus the sector average of 43.86, creating significant margin of safety. Analysts reflect this optimism with a $170.63 target price, implying ~41% upside, supported by durable cash flows and a disciplined capital allocation strategy including a sustainable 1.66% dividend yield.

Strengths
Exceptional profitability: 39.33% operating margin vs. sector avg of 15.98%
Superior return metrics: 49.87% ROE vs. sector avg of 42.28%
Consistent earnings outperformance: 3 of last 4 quarters beat estimates, with 5.47% avg surprise
Risks
Low revenue growth: YoY revenue growth of only 0.50% raises concerns about top-line momentum
High debt burden: Debt/Equity of 1.35 exceeds sector average of 1.15 and peer group levels
Price underperformance: 5Y return of -23.5% and 1Y return of -29.9% reflect investor skepticism

Compare Another Pair

BDX vs ZTS: Head-to-Head Comparison

This page compares Becton, Dickinson and Company (BDX) and Zoetis Inc. (ZTS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile